Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1196679 | 1.00 | TP53 (0.42) | TP53SLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL607461 | 1.00 | TP53 (0.42) | TP53SLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL26940411 | 0.88 | MMP1 (0.46) | TP53SLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL29342143 | 0.88 | MMP1 (0.46) | TP53SLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL13143752 | 0.82 | SLC1A3 (0.43) | TP53SLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL26940424 | 0.80 | ALDH1A1 (0.42) | TP53SLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL11337345 | 0.79 | TP53 (0.40) | TP53SLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL15279752 | 0.78 | RNPEP (0.41) | SLC1A3SLC1A2MMP1MMP2MMP3 | |
| SCHEMBL2348726 | 0.78 | MMP1 (0.31) | TP53SLC1A3SLC1A2SLC1A1MMP1 | |
| SCHEMBL10591095 | 0.76 | SLC1A3 (0.48) | TP53SLC1A3SLC1A2SLC1A1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011161690-A1 | PROCESSES FOR THE PREPARATION OF (+)-N,N-DIMETHYL-2-[1-(NAPHTHALENYLOXY) ETHYL] BENZENE METHANAMINE AND INTERMEDIATES THEREOF | SYMED LABS LIMITED (IN) | 2011-12-29 | — | — | WO | claimed |
| WO-1999031353-A1 | STABILIZING CLAYEY FORMATIONS | SOFITECH N.V. (BE) | 1999-06-24 | — | — | WO | claimed |
| EP-0512222-B1 | Stereo and enantioselective synthesis of tetrahydro-5-substituted-3-methylene-2-furanmethanols | AMERICAN CYANAMID CO (US) | 1996-02-21 | — | — | EP | claimed |
| EP-0540807-B1 | Asymmetric synthesis of 3-substituted furanoside compounds | AMERICAN CYANAMID CO (US) | 1995-12-27 | — | — | EP | claimed |
| US-5216145-A | Conensation, reduction, epoxidation, ring opening, oxidation, hydrogenation, alcoholysis | AMERICAN CYANAMID COMPANY (US) | 1993-06-01 | — | — | US | claimed |
| EP-0540807-A1 | Asymmetric synthesis of 3-substituted furanoside compounds | AMERICAN CYANAMID COMPANY (US) | 1993-05-12 | — | — | EP | claimed |
| WO-2023109944-A1 | TLR MODULATOR AND USE THEREOF | 映恩生物制药（苏州）有限公司 | 2023-06-22 | — | — | WO | disclosed |
| WO-2023025248-A1 | STEROID COMPOUND AND CONJUGATE THEREOF | 映恩生物制药（苏州）有限公司 | 2023-03-02 | — | — | WO | disclosed |
| EP-2890415-B1 | CHLORHEXIDINE GLUCONATE COMPOSITIONS, RESIN SYSTEMS AND ARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2020-09-23 | — | — | EP | disclosed |
| US-20200030499-A1 | CHLORHEXIDINE GLUCONATE COMPOSITIONS RESIN SYSTEMS AND ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2020-01-30 | — | — | US | disclosed |
| US-10456509-B2 | Chlorhexidine gluconate compositions, resin systems and articles | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-10-29 | — | — | US | disclosed |
| US-20190160209-A1 | CHLORHEXIDINE GLUCONATE COMPOSITIONS, RESIN SYSTEMS AND ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-05-30 | — | — | US | disclosed |
| US-10232093-B2 | Chlorhexidine gluconate compositions, resin systems and article | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-03-19 | — | — | US | disclosed |
| US-5296620-A | Hexenol derivatives as intermediates for compounds for treatment of AIDS virus infections | AMERICAN CYANAMID COMPANY (US) | 1994-03-22 | — | — | US | disclosed |
| EP-0338600-B1 | PROCESS FOR THE PREPARATION OF PROLINOLAMIDE DERIVATIVES | MERCK & CO. INC. (US) | 1993-06-02 | — | — | EP | disclosed |
| US-5216145-A | Conensation, reduction, epoxidation, ring opening, oxidation, hydrogenation, alcoholysis | AMERICAN CYANAMID COMPANY (US) | 1993-06-01 | — | — | US | disclosed |
| EP-0540807-A1 | Asymmetric synthesis of 3-substituted furanoside compounds | AMERICAN CYANAMID COMPANY (US) | 1993-05-12 | — | — | EP | disclosed |
| US-5175335-A | Reacting vinyl aryl compounds with a source of hydrocyanic acid in presence of nickle zero valent compound and nonracemic bidentate organophosphorus ligand | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-12-29 | — | — | US | disclosed |
| US-5087703-A | 2-Methyl-4-hydroxy-5-protected hydroxy-hept-6-en-prolinolamides | MERCK & CO., INC. (US) | 1992-02-11 | — | — | US | disclosed |
| EP-0338600-A1 | Process for the preparation of prolinolamide derivatives | MERCK & CO. INC. (US) | 1989-10-25 | — | — | EP | disclosed |